Contraindications: Testosterone Cypionate is contraindicated in individuals with androgen-sensitive malignancies (prostate or breast carcinoma), active polycythaemia, severe untreated sleep apnoea, or hypersensitivity to any oil-based injectable component. Professional athletes with pre-existing cardiovascular structural abnormalities should obtain cardiology clearance before initiating supraphysiological androgen doses.
Side Effects: Supraphysiological testosterone use in professionals carries risks including erythrocytosis, suppression of spermatogenesis, androgenic alopecia in genetically predisposed individuals, elevated haematocrit, dyslipidaemia (reduced HDL), and peripheral aromatisation producing excess estradiol. Progestogenic side effects are uncommon with testosterone cypionate alone but may emerge in complex multi-compound stacks.
Monitoring: Professional users should schedule comprehensive bloodwork every six weeks during active phases: full blood count (haematocrit, haemoglobin), lipid panel, serum testosterone (total and free), estradiol, PSA where age-appropriate, and liver enzyme panel. Blood pressure should be self-monitored weekly given the sodium- and fluid-retention potential at higher weekly doses.
PCT: After completing a professional testosterone protocol, allow sufficient time for the depot to clear before initiating SERM-based post-cycle therapy. Bloodwork confirmation of LH/FSH suppression depth should inform PCT compound selection and duration. Failure to confirm HPG-axis recovery before discontinuing PCT is a common error in competitive populations.